Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with a

• 作 者: Bo Zhang Xi Wang Qun Li Hongna
• 机 构: DepartmentofMedicalOncology
• 出 处: 中国癌症研究:英文版
• 发表日期: 2019年6期
• 关键词: ESOPHAGEAL SQUAMOUS cell carcinoma IRINOTECAN IMMUNOTHERAPY treatment outcomes
• 基金项目: supported by the Capital’s Funds for Health Improvement and Research(No.CFH2018-44024)

Objective:Several anti-programmed cell death 1(anti-PD-1)antibodies have demonstrated potential efficacy in the treatment of advanced esophageal squamous cell cancer(ESCC).However,the response to subsequent chemotherapy after the failure of PD-1 blockade